Jan Beumer
0000-0002-8978-9401
4 papers found
Refreshing results…
Randomized Phase III Study of Enzalutamide Compared With Enzalutamide Plus Abiraterone for Metastatic Castration-Resistant Prostate Cancer (Alliance A031201 Trial)
The schedule of ATR inhibitor AZD6738 can potentiate or abolish antitumor immune responses to radiotherapy
Dasatinib and dexamethasone followed by hematopoietic cell transplantation for adults with Ph-positive ALL
Secondary Cytoreduction and Carboplatin Hyperthermic Intraperitoneal Chemotherapy for Platinum-Sensitive Recurrent Ovarian Cancer: An MSK Team Ovary Phase II Study
Missing publications? Search for publications with a matching author name.